Neboglamine (hydrochloride)

Neboglamine (CR-2249, XY-2401) hydrochloride is an orally active NMDA receptor glycine site positive modulator that can be used in schizophrenia research[1].

Product Specifications

CAS Number

[2759182-59-5]

Product Name Alternative

CR-2249 (hydrochloride) ; XY-2401 (hydrochloride)

UNSPSC

12352211

Target

IGluR

Type

Reference compound

Related Pathways

Membrane Transporter/Ion Channel; Neuronal Signaling

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/neboglamine-hydrochloride.html

Purity

97.02

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

OC(CC[C@H](N)C(NC1CCC(C)(CC1)C)=O)=O.Cl

Molecular Formula

C13H25ClN2O3

Molecular Weight

292.80

References & Citations

[1]Riccardo Chiusaroli, et al. Antipsychotic-like effects of the N-methyl-D-aspartate receptor modulator neboglamine: an immunohistochemical and behavioural study in the rat. Pharmacol Res. 2010 May;61 (5) :430-6.